UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.74 +0.72 (+0.92%) GOLD FUTURES
2,391.10 +31.20 (+1.32%) DOW
39,837.24 +279.13 (+0.71%) Bitcoin GBP
51,543.18 +3,128.66 (+6.46%)
Wave Life Sciences Ltd. (WVE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:55PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 715.17M |
| Enterprise value | 564.78M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.84 |
| Price/book (mrq) | 28.17 |
| Enterprise value/revenue | 5.00 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | -1.00 |
| 52-week change 3 | 59.13% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 7.67 |
| 52-week low 3 | 3.15 |
| 50-day moving average 3 | 5.77 |
| 200-day moving average 3 | 5.15 |
Share statistics
| Avg vol (3-month) 3 | 903.28k |
| Avg vol (10-day) 3 | 781.56k |
| Shares outstanding 5 | 122.46M |
| Implied shares outstanding 6 | 125.37M |
| Float 8 | 67.42M |
| % held by insiders 1 | 18.18% |
| % held by institutions 1 | 76.66% |
| Shares short (30 Apr 2024) 4 | 2.78M |
| Short ratio (30 Apr 2024) 4 | 5.32 |
| Short % of float (30 Apr 2024) 4 | 3.32% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.27% |
| Shares short (prior month 28 Mar 2024) 4 | 3.59M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -54.61% |
| Operating margin (ttm) | -274.83% |
Management effectiveness
| Return on assets (ttm) | -17.95% |
| Return on equity (ttm) | -1,920.16% |
Income statement
| Revenue (ttm) | 112.91M |
| Revenue per share (ttm) | 1.00 |
| Quarterly revenue growth (yoy) | -3.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -67.56M |
| Net income avi to common (ttm) | -61.67M |
| Diluted EPS (ttm) | -0.51 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 180.92M |
| Total cash per share (mrq) | 1.48 |
| Total debt (mrq) | 30.53M |
| Total debt/equity (mrq) | 91.80% |
| Current ratio (mrq) | 1.19 |
| Book value per share (mrq) | 0.21 |
Cash flow statement
| Operating cash flow (ttm) | -138.38M |
| Levered free cash flow (ttm) | 1.36M |
© 2024 Yahoo. All rights reserved.